ES2095243T3 - Proteina de actividad urato oxidasa; gen recombinante codante para esta, vector de expresion, micro-organismos y celulas transformadas. - Google Patents

Proteina de actividad urato oxidasa; gen recombinante codante para esta, vector de expresion, micro-organismos y celulas transformadas.

Info

Publication number
ES2095243T3
ES2095243T3 ES90402023T ES90402023T ES2095243T3 ES 2095243 T3 ES2095243 T3 ES 2095243T3 ES 90402023 T ES90402023 T ES 90402023T ES 90402023 T ES90402023 T ES 90402023T ES 2095243 T3 ES2095243 T3 ES 2095243T3
Authority
ES
Spain
Prior art keywords
urato
organisms
vector
micro
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90402023T
Other languages
English (en)
Inventor
Daniel Caput
Pascual Ferrara
Jean Claude Guillemot
Mourad Kaghad
Richard Legoux
Gerard Loison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8909550A external-priority patent/FR2649720A1/fr
Priority claimed from FR8917466A external-priority patent/FR2656530B1/fr
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of ES2095243T3 publication Critical patent/ES2095243T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Glass Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UNA NUEVA PROTEINA CON ACTIVIDAD URATO OXIDASA QUE TIENE LA SECUENCIA SIGUIENTE: SER ALA VAL LYS ALA ALA ARG TYR GLY LYS ASP ASN VAL ARG VAL TYR LYS VAL HIS LYS ASP GLU LYS THR GLY VAL GLN THR VAL TYR GLU MET THR VAL CYS VAL LEU LEU GLU GLY GLU ILE GLU THR SER TYR THR LYS ALA ASP ASN SER VAL ILE VAL ALA THR ASP SER ILE LYS ASN THR ILE TYR ILE THR ALA LYS GLN ASN PRO VAL THR PRO PRO GLU LEU PHE GLY SER ILE LEU GLY THR LYS PHE ILE GLU LYS TYR ASN HIS ILE HIS ALA ALA HIS VAL ASN ILE VAL CYS HIS ARG TRP THR ARG MET ASP ILE ASP GLY LYS PRO HIS PRO HIS SER PHE ILE ARG ASP SER GLU GLU LYS ARG ASN VAL GLN VAL ASP VAL VAL GLU GLY LYS ILE ASP ILE LYS SER SER LEU SER GLY LEU THR VAL LEU LYS SER THR ASN SER GLN PHE TRP GLY PHE LEU ARG ASP GLU TYR THR THR LEU LYS GLU THR TRP ASP ARG ILE LEU SER THR ASP VAL ASP ALA THR TRP GLN TRP LYS ASN PHE SER GLY LEU GLN GLU VAL ARG SER HIS VAL PRO LYS PHE ASP ALA THR TRP ALA THR ALA ARG GLU VAL THR LEU LYS THR PHE ALA GLU ASP ASN SER ALA SER VAL GLN ALA THR MET TYR LYS MET ALA GLU GLN ILE LEU ALA ARG GLN GLN LEU ILE GLU THR VAL GLU TYR SER LEU PRO ASN LYS HIS TYR PHE GLU ILE ASP LEU SER TRP HIS LYS GLY LEU GLN ASN THR GLY LYS ASN ALA GLU VAL PHE ALA PRO GLN SER ASP PRO ASN GLY LEU ILE LYS CYS THR VAL GLY ARG SER SER LEU LYS SER LYS LEU, PRECEDIDO EVENTUALMENTE DE UNA METIONINA, O EN QUE PRESENTA UN GRADO DE HOMOLOGIA SUSTANCIAL CON ESTA SECUENCIA. LA INVENCION TIENE POR OBJETO IGUALMENTE LOS MEDICAMENTOS QUE CONTIENEN ESTA PROTEINA ASI COMO LOS UTILES DE INGENIERIA GENETICA PARA OBTENERLA.
ES90402023T 1989-07-13 1990-07-13 Proteina de actividad urato oxidasa; gen recombinante codante para esta, vector de expresion, micro-organismos y celulas transformadas. Expired - Lifetime ES2095243T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8909550A FR2649720A1 (en) 1989-07-13 1989-07-13 Recombinant gene which encodes a protein such as urate oxidase
FR8917466A FR2656530B1 (fr) 1989-12-29 1989-12-29 Gene recombinant pour une expression dans les cellules eucaryotes d'une proteine telle que l'urate oxydase.
FR9001368A FR2657785A2 (fr) 1989-12-29 1990-02-06 Gene recombinant pour une expression dans les cellules animales d'une proteine telle que l'urate oxydage.

Publications (1)

Publication Number Publication Date
ES2095243T3 true ES2095243T3 (es) 1997-02-16

Family

ID=27251947

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90402023T Expired - Lifetime ES2095243T3 (es) 1989-07-13 1990-07-13 Proteina de actividad urato oxidasa; gen recombinante codante para esta, vector de expresion, micro-organismos y celulas transformadas.

Country Status (24)

Country Link
EP (1) EP0408461B1 (es)
JP (1) JP2664804B2 (es)
AT (1) ATE144282T1 (es)
AU (1) AU636637B2 (es)
BR (1) BR9006855A (es)
CA (1) CA2035900C (es)
DE (2) DE69028884T2 (es)
DK (1) DK0408461T3 (es)
ES (1) ES2095243T3 (es)
FI (1) FI105047B (es)
GR (1) GR3022085T3 (es)
HK (1) HK1000099A1 (es)
HU (1) HU215948B (es)
IE (1) IE77158B1 (es)
IL (1) IL95057A (es)
LU (1) LU90781I2 (es)
LV (1) LV12000B (es)
MC (1) MC2145A1 (es)
NL (1) NL300046I2 (es)
NO (1) NO2001018I2 (es)
NZ (1) NZ234453A (es)
PT (1) PT94680B (es)
RU (1) RU2105812C1 (es)
WO (1) WO1991000909A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2971218B2 (ja) * 1991-12-04 1999-11-02 協和醗酵工業株式会社 ウリカーゼ遺伝子およびウリカーゼの製造法
US5691188A (en) 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
EP0935651B1 (en) * 1996-09-13 2004-12-29 Transkaryotic Therapies, Inc. THERAPY FOR alpha-GALACTOSIDASE A DEFICIENCY
US6083725A (en) 1996-09-13 2000-07-04 Transkaryotic Therapies, Inc. Tranfected human cells expressing human α-galactosidase A protein
CN1896231B (zh) 1998-08-06 2012-09-05 山景药品公司 分离四聚体尿酸氧化酶的方法
US6783965B1 (en) * 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
CN1275980C (zh) 2000-08-17 2006-09-20 味之素株式会社 来源于微生物的转谷氨酰胺酶的修饰方法
ES2367257T3 (es) 2002-04-25 2011-10-31 Shire Human Genetic Therapies, Inc. Tratamiento de deficit de alfa-galactosidasa a.
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
BRPI0612942A2 (pt) 2005-04-11 2012-10-09 Savient Pharmaceuticals Inc forma variante de oxidase de urato e uso do mesmo
CA2604399A1 (en) 2005-04-11 2006-10-19 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
US9534013B2 (en) 2006-04-12 2017-01-03 Horizon Pharma Rheumatology Llc Purification of proteins with cationic surfactant
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
RU2443426C2 (ru) * 2008-11-07 2012-02-27 Мунтэн Вью Фармасьютикэлз, Инк. Конъюгаты уратоксидазы, фармацевтическая композиция для снижения уровней мочевой кислоты и способ получения вышеупомянутых конъюгатов
EP3482768A1 (en) 2009-06-25 2019-05-15 Horizon Pharma Rheumatology LLC Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
CN109223707B (zh) * 2018-09-13 2020-12-08 中国药科大学 一种尿酸酶外用凝胶制剂、其制备方法及用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1529675A (fr) * 1967-03-29 1968-06-21 Applic Biochimiques Soc Et Urate oxydase à haute activité et sa préparation
SU457723A1 (ru) * 1973-04-09 1977-08-05 Всесоюзный Научно-Исследовательский Витаминный Институт Штамм 313-152 - продуцент уратоксидазы
EP0173378B1 (en) * 1984-07-27 1991-06-12 Unilever N.V. Process for preparing a polypeptide by culturing a transformed microorganism, a transformed microorganism suitable therefor and dna sequences suitable for preparing such microorganism
WO1988008450A1 (en) * 1987-05-01 1988-11-03 Birdwell Finlayson Gene therapy for metabolite disorders
JPH0671428B2 (ja) * 1988-08-17 1994-09-14 サッポロビール株式会社 ウリカーゼのdna配列および製法

Also Published As

Publication number Publication date
EP0408461B1 (fr) 1996-10-16
AU6052390A (en) 1991-02-06
MC2145A1 (fr) 1992-02-18
WO1991000909A1 (fr) 1991-01-24
HK1000099A1 (en) 1997-11-21
NL300046I2 (nl) 2001-12-01
DK0408461T3 (da) 1997-03-24
FI105047B (fi) 2000-05-31
JPH04501807A (ja) 1992-04-02
PT94680B (pt) 1997-04-30
DE69028884T2 (de) 1997-05-07
NO2001018I2 (no) 2006-05-01
DE69028884D1 (de) 1996-11-21
DE10199042I1 (de) 2002-01-10
LV12000B (lv) 1998-06-20
LV12000A (lv) 1998-03-20
HUT56884A (en) 1991-10-28
IL95057A (en) 1997-07-13
GR3022085T3 (en) 1997-03-31
NL300046I1 (nl) 2001-09-03
IL95057A0 (en) 1991-06-10
RU2105812C1 (ru) 1998-02-27
IE77158B1 (en) 1997-12-03
ATE144282T1 (de) 1996-11-15
CA2035900C (fr) 2000-01-11
FI911212A0 (fi) 1991-03-12
AU636637B2 (en) 1993-05-06
NZ234453A (en) 1993-01-27
BR9006855A (pt) 1991-08-06
CA2035900A1 (fr) 1991-01-14
HU215948B (hu) 1999-03-29
PT94680A (pt) 1991-04-18
HU906046D0 (en) 1991-07-29
JP2664804B2 (ja) 1997-10-22
IE902559A1 (en) 1991-02-27
DE10199042I2 (de) 2003-10-23
EP0408461A1 (fr) 1991-01-16
LU90781I2 (fr) 2001-07-23

Similar Documents

Publication Publication Date Title
ES2095243T3 (es) Proteina de actividad urato oxidasa; gen recombinante codante para esta, vector de expresion, micro-organismos y celulas transformadas.
DE69635452D1 (de) Hohe expressionsrate des grün-fluoreszierenden proteins
DK1003379T3 (da) Hidtil ukendt phytase
GR940300052T1 (en) Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms.
ES2124694T3 (es) Clonacion de la n-metil-hidantoinasa.
ES2114555T3 (es) Nuevo interferon gamma humano recombinado.
ATE271125T1 (de) Neuartige tyrosinkinase
DE59109126D1 (de) N-Carbamoylsarcosin-Amidohydrolase, kloniert
ATE158614T1 (de) Für ein protein, das sich mit dem enhancer des alpha-fetoprotein verbindet, kodierende dns

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 408461

Country of ref document: ES

SPCF Request for supplementary protection certificate filed

Free format text: RASBURICASA (FASTURTEC).

Spc suppl protection certif: C200100022

Filing date: 20010803

Free format text: RASBURICASA (FASTURTEC)

Spc suppl protection certif: C200100022

Filing date: 20010803

SPCG Supplementary protection certificate granted

Free format text: RASBURICASA (FASTURTEC)

Spc suppl protection certif: C200100022

Filing date: 20010803

Expiry date: 20150713

Effective date: 20031205